366
Views
2
CrossRef citations to date
0
Altmetric
Original Scientific Contributions

A fatal ranolazine overdose after an intentional ingestion

ORCID Icon, , , , &
Pages 213-214 | Received 25 Feb 2019, Accepted 07 May 2019, Published online: 23 May 2019

References

  • Codolosa J, Acharjee S, Figueredo V. Update on ranolazine in the management of angina. Vasc Health Risk Manag. 2014;10:353.
  • Jerling M. Clinical Pharmacokinetics of Ranolazine. Clin Pharmacokinet. 2006;45:469–91.
  • Bengel P, Ahmad S, Sossalla S. Inhibition of late sodium current as an innovative antiarrhythmic strategy. Curr Heart Fail Rep. 2017;14:179–186.
  • Zhao G, Walsh E, Shryock JC, et al. Antiadrenergic and hemodynamic effects of ranolazine in conscious dogs. J Cardiovasc Pharmacol. 2011;57:639–647.
  • Maier LS, Layug B, Karwatowska-Prokopczuk E, et al. Ranolazine for the treatment of diastolic heart failure in patients with preserved ejection fraction. JACC Heart Fail. 2013;2:115–122.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.